• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK; IN-VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK; IN-VITRO DIAGNOSTIC Back to Search Results
Catalog Number 1912997
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/21/2017
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that lower than expected vitros tsh results were obtained from a single cap linearity sample ln5-14, tested on a vitros 5600 integrated system.A definitive assignable cause for the lower than expected vitros tsh cap linearity results could not be determined.Based on historical quality control results, a vitros tsh lot 5550 performance issue is not a likely contributor to the event.Follow up testing which included a dilution study with a patient sample with a tsh level >100miu/ml, and testing of vitros tsh range verifiers demonstrated vitros tsh lot 5550 is performing as expected.While a vitros tsh within-run precision test met performance guidelines, an instrument issue cannot be completely ruled out as several weeks had elapsed between the time of the event and the precision test.In addition, an interaction with the cap sample fluid matrix cannot be ruled out.A definitive assignable cause for the event could not be determined.
 
Event Description
A customer obtained lower than expected vitros tsh results from a (b)(4) linearity sample tested on a vitros 5600 integrated system.Cap sample ln5-14 results of 43.1 and 43.2 miu/l vs.The expected result of 63.0312 miu/l biased results of the direction and magnitude observed may lead to inappropriate physician action.The lower than expected vitros tsh results were generated from non-patient fluid and the customer did not give any indication that patient results had been affected, however, the investigation could not rule out that patient samples were not, or would not be affected if the event were to recur undetected.There was no allegation of actual patient harm as a result of this event.This report corresponds to ortho clinical diagnostics inc.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTIC
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key7312424
MDR Text Key102079169
Report Number3007111389-2018-00027
Device Sequence Number1
Product Code JLW
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 03/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/29/2018
Device Catalogue Number1912997
Device Lot Number5550
Other Device ID Number10758750000227
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 02/07/2018
Initial Date FDA Received03/05/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/25/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-